2,6-Dihydroxy-pyrimidin-4-carbonsaeure-ethyl-amid | 1011-82-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2,6-Dihydroxy-pyrimidin-4-carbonsaeure-ethyl-amid
• 英文别名: Orotsaeure-ethylamid；Orotsaeure-aethylamid；2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid ethylamide；N-ethyl-2,4-dioxo-1H-pyrimidine-6-carboxamide
• CAS: 1011-82-1
• 化学式: C₇H₉N₃O₃
• mdl: MFCD19595618
• 分子量: 183.167
• InChiKey: AUOOYBFIURXCAF-UHFFFAOYSA-N

物化性质

• 熔点：
  264°C
• 沸点：
  316.83°C (rough estimate)
• 密度：
  1.3803 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.285
• 拓扑面积：
  87.3
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
  申请人：GLYCOMIMETICS, INC.

  公开号：US11197877B2

  公开（公告）日：2021-12-14

  Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, E-selectin antagonists are described and pharmaceutical compositions comprising at least one of the same.

  本文公开了通过抑制 E-选择素与 E-选择素配体的结合来治疗和/或预防至少一种疾病、失调和/或病症的化合物、组合物和方法。例如，描述了 E-选择素拮抗剂和包含至少一种 E-选择素拮抗剂的药物组合物。
• GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS
  申请人：GLYCOMIMETICS, INC.

  公开号：US20200129536A1

  公开（公告）日：2020-04-30

  Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, E-selectin antagonists are described and pharmaceutical compositions comprising at least one of the same.
• Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker
  申请人：GlycoMimetics, Inc.

  公开号：US20200171005A9

  公开（公告）日：2020-06-04

  Compounds, compositions, and methods for modulating in vitro and in vivo processes mediated by selectin binding. For example, heterobifunctional compounds that inhibit both E-selectins and P-selectins are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids). The compounds are of formula (Ia) wherein the substituents are as defined in the claims.